Chris Skidmore says joining the EU’s €94.1B research programme after Brexit remains a priority, but admits in some areas UK may need to “fill the gaps”. Scientists, meanwhile, fear that EU election results make crashing-out more likely
Autonomous vehicles, 6G mobile and an expansion of the Innovative Medicines Initiative to take in medical devices, diagnostics, vaccines and biopharmaceuticals are on the list of public-private partnerships. Six existing partnerships march on, with fresh objectives
In a new series, experts weigh in on the big priorities for the next term of the European Commission and the Parliament. In this first instalment, the focus is on shaping the EU’s new research programme, Horizon Europe
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.